Awm Investment Company, Inc. Clearside Biomedical, Inc. Transaction History

Awm Investment Company, Inc.

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2018 Feb 13, 2019	SELL	$1.0 - $6.12 $875,126 - $5.36 Million	-875,126 Closed	0 $0
Q3 2018 Nov 09, 2018	BUY	$6.03 - $11.24 $1.27 Million - $2.36 Million	210,131 Added 31.6%	875,126 $5.38 Million
Q2 2018 Aug 09, 2018	BUY	$8.91 - $14.54 $934,124 - $1.52 Million	104,840 Added 18.72%	664,995 $7.11 Million
Q1 2018 May 10, 2018	BUY	$5.57 - $14.28 $2.51 Million - $6.43 Million	450,155 Added 409.23%	560,155 $6.01 Million
Q4 2017 Feb 13, 2018	BUY	$5.78 - $9.12 $44,945 - $70,917	7,776 Added 7.61%	110,000 $770,000
Q3 2017 Nov 14, 2017	BUY	$6.73 - $8.74 $687,967 - $893,437	102,224	102,224 $893,000

12M

36.2K

36.3K

Ticker CLSD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 60,190,700
Market Cap $64.4M
Description
Clearside Biomedical, Inc., a biopharmaceutical company, focuses on the revolutionizing the delivery of therapies to the back of the eye through the suprachoroidal space. The company offers XIPERE, a triamcinolone acetonide suprachoroidal injectable suspension for the treatment of uveitis macular edema. It also develops CLS-AX, an axitinib injec...

Get notified when there are updates to the investment portfolio of Awm Investment Company, Inc., based on Form 13F filings with the SEC.

Stay updated on Awm Investment Company, Inc. with notifications on news.